Skip to main content
. 2022 May 6;101(17):e29167. doi: 10.1097/MD.0000000000029167

Table 2.

Univariate analysis of factors for risk of poor prognosis.

Variables Good prognosis (n = 83) Poor prognosis (n = 62) Statistical magnitude P
Gender, n (%) χ2 = 0.001 .972
Male 56 (67.47) 42 (67.74)
Female 27 (32.53) 20 (32.26)
Age, Mean ± SD 59.89 ± 11.38 64.74 ± 11.20 t = –2.56 .012
BMI, n (%) χ2 = 4.461 .035
>23.9 49 (59.04) 47 (75.81)
≤23.9 34 (40.96) 15 (24.19)
Fever on admission, n (%) 1.000
Yes 6 (7.23) 4 (6.45)
No 77 (92.77) 58 (93.55)
Baseline mRs score, n (%) 1.000
>2 82 (98.80) 62 (100.00)
≤2 1 (1.20) 0
Baseline NIHSS score, Mean ± SD 23.06 ± 7.44 30.82 ± 6.89 t = –6.412 <.001
Pc-ASPECT score, Mean ± SD 7.53 ± 1.11 6.23 ± 1.18 t = 6.822 <.001
DSA-ASITN grading, n (%) Z = 5.946 <.001
Level 0 40 (48.19) 7 (11.29)
Level 1 18 (21.69) 6 (9.68)
Level 2 12 (14.46) 11 (17.74)
Level 3 3 (3.61) 13 (20.97)
Level 4 10 (12.05) 25 (40.32)
History of smoking, n (%) χ2 = 0.046 .830
No 36 (43.37) 28 (45.16)
Yes 47 (56.63) 34 (54.84)
History of drinking, n (%) χ2 = 0.198 .657
No 63 (75.90) 49 (79.03)
Yes 20 (24.10) 13 (20.97)
History of hypertension, n (%) χ2 = 2.680 .102
No 18 (21.69) 21 (33.87)
Yes 65 (78.31) 41 (66.13)
History of diabetes, n (%) χ2 = 0.507 .476
No 62 (74.70) 43 (69.35)
Yes 21 (25.30) 19 (30.65)
History of hyperlipemia, n (%) χ2 = 0.764 .382
No 76 (91.57) 54 (87.10)
Yes 7 (8.43) 8 (12.90)
History of stroke, n (%) χ2 = 0.973 .324
No 72 (86.75) 57 (91.94)
Yes 11 (13.25) 5 (8.06)
Length of thrombus, Mean ± SD 13.94 ± 9.16 14.48 ± 9.08 t = –0.355 .723
rt-PA, n (%) 11 (13.25) 13 (20.97) χ2 = 1.529 .216
Number of thrombectomy, n (%) - .428
Yes 0 (0.00) 1 (1.61)
No 83 (100.00) 61 (98.39)
Time to revascularization, h, Mean ± SD 1.65 ± 0.71 1.94 ± 0.85 t = –2.183 .031
Time to procedure, h, Mean ± SD 9.58 ± 5.16 8.19 ± 3.67 t = 1.889 .061
Procedure time, h, Mean ± SD 10.01 ± 5.17 8.61 ± 3.63 t = 1.924 .056
TOAST classification, n (%) - .001
Large artery atherosclerosis 71 (85.54) 43 (69.35)
Cardioembolism 5 (6.02) 17 (27.42)
Others 7 (8.43) 2 (3.23)
Occlusion sites, n (%) χ2 = 1.949 .583
Proximal basilar artery 1 16 (19.28) 14 (22.58)
Middle Basilar 2 18 (21.69) 18 (29.03)
Distal basilar artery 3 35 (42.17) 23 (37.10)
Vertebral artery V4 14 (16.87) 7 (11.29)
Pathogenesis of stroke, n (%) - .082
Simple embolic occlusion of basilar artery 13 (15.66) 18 (29.03)
Acute occlusion based on basilar artery stenosis 44 (53.01) 33 (53.23)
Tandem Lesions 25 (30.12) 10 (16.13)
Others 1 (1.20) 1 (1.61)
Recanalization, n (%) 83 (100.0) 61 (98.39) .428
NIHSS score at 24 h, Mean ± SD 15.28 ± 6.33 29.87 ± 7.95 t = –12.302 <.001
Pulmonary infection, n (%) 57 (68.67) 59 (95.16) χ2 = 15.561 <.001
Trachea cannula, n (%) 3 (3.61) 52 (83.87) χ2 = 97.094 <.001
Circulatory collapse, n (%) 0 (0.00) 30 (48.39) χ2 = 50.638 <.001

ASPECT = Alberta Stroke Program Early CT, BMI = body mass index, DSA-ASITN = digital subtraction angiography-American Society of Intervention and Therapeutic Neuroradiology, mRs = modified Rankin scale, NIHSS = National Institute of Health stroke scale; rt-PA = recombinant tissue plasminogen activator; SD = standard deviation; TOAST = Trial of Org 10,172 in Acute Stroke Treatment.